Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Divalproex sodium add-on to risperidone in Batak and non-Batak men with schizophrenia
ISRCTN16522451Phase 3Completed
- Sponsor
- Universitas Sumatera Utara
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of divalproex sodium and risperidone in schizophrenia (4 arms), sponsored by Universitas Sumatera Utara. Primary endpoint: Change in schizophrenia symptoms. Started Sep 2017; status: completed.
02
Drugs
divalproex sodiumrisperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on ISRCTN16522451.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN16522451.